MIM
FTXH icon

Marshall Investment Management’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Marshall Investment Management’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Sell
38,080
-7,152
-16% -$249K 0.6% 47
2026
Q1 		$1.55M Buy
45,232
+3,423
+8% +$117K 0.75% 45
2025
Q4 		$1.38M Buy
+41,809
New +$1.3M 0.69% 43

Other funds holding FTXH

LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.75B AUM 46.53% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Marshall Investment Management's FTXH Position: Q2 2026 in Review

Marshall Investment Management reduced its First Trust Nasdaq Pharmaceuticals ETF (FTXH) stake by 16% in Q2 2026, selling an estimated $249K and leaving 38,080 shares worth $1.45M. The position accounts for 0.6% of the portfolio, ranked #47.

Marshall Investment Management first reported a position in FTXH in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.55M in Q1 2026. 30 funds tracked by Wall St. Rank hold FTXH as of Q2 2026.

  • Marshall Investment Management held 38,080 shares of First Trust Nasdaq Pharmaceuticals ETF worth $1.45M as of Q2 2026.
  • Marshall Investment Management sold 7,152 First Trust Nasdaq Pharmaceuticals ETF shares in Q2 2026, an estimated $249K.
  • First Trust Nasdaq Pharmaceuticals ETF made up 0.6% of Marshall Investment Management's portfolio in Q2 2026, its #47 holding.
  • Marshall Investment Management first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2025 and has held it in 3 quarters since.
  • Marshall Investment Management's First Trust Nasdaq Pharmaceuticals ETF position peaked at $1.55M in Q1 2026.
  • 30 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2026.

Based on Marshall Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.